These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 15667972

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
    Alektiar KM, Brennan MF, Singer S.
    Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):202-8. PubMed ID: 16111590
    [Abstract] [Full Text] [Related]

  • 4. The role of radiotherapy in oseosarcoma.
    Schwarz R, Bruland O, Cassoni A, Schomberg P, Bielack S.
    Cancer Treat Res; 2009 Sep 01; 152():147-64. PubMed ID: 20213389
    [Abstract] [Full Text] [Related]

  • 5. Dose response and local control using radiotherapy in non-metastatic Ewing sarcoma.
    Paulino AC, Nguyen TX, Mai WY, Teh BS, Wen BC.
    Pediatr Blood Cancer; 2007 Aug 01; 49(2):145-8. PubMed ID: 16732580
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment.
    Guadagnolo BA, Zagars GK, Raymond AK, Benjamin RS, Sturgis EM.
    Cancer; 2009 Jul 15; 115(14):3262-70. PubMed ID: 19382187
    [Abstract] [Full Text] [Related]

  • 9. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery?
    Jaffe N, Carrasco H, Raymond K, Ayala A, Eftekhari F.
    Cancer; 2002 Nov 15; 95(10):2202-10. PubMed ID: 12412175
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.
    Ortholan C, Ramaioli A, Peiffert D, Lusinchi A, Romestaing P, Chauveinc L, Touboul E, Peignaux K, Bruna A, de La Roche G, Lagrange JL, Alzieu C, Gerard JP.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):479-85. PubMed ID: 15890590
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dose-response relationship in locoregional control for patients with stage II-III esophageal cancer treated with concurrent chemotherapy and radiotherapy.
    Zhang Z, Liao Z, Jin J, Ajani J, Chang JY, Jeter M, Guerrero T, Stevens CW, Swisher S, Ho L, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2005 Mar 01; 61(3):656-64. PubMed ID: 15708243
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.